Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

INSM

Insmed (INSM)

Insmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INSM
DateHeureSourceTitreSymboleSociété
07/11/201213h34Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INSMInsmed Inc
07/11/201213h34Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:INSMInsmed Inc
07/11/201213h26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INSMInsmed Inc
07/11/201213h26Edgar (US Regulatory)Current report filing (8-K)NASDAQ:INSMInsmed Inc
07/11/201213h15PR Newswire (US)Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2012NASDAQ:INSMInsmed Inc
07/11/201213h00PR Newswire (US)Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial OfficerNASDAQ:INSMInsmed Inc
02/11/201214h09Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INSMInsmed Inc
02/11/201214h09Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INSMInsmed Inc
24/10/201214h00PR Newswire (US)Insmed to Host 2012 Third Quarter Earnings Conference CallNASDAQ:INSMInsmed Inc
23/10/201223h00MarketwiredNuPathe Announces Closing of $28 Million Private Placement and Changes to Its Board of DirectorsNASDAQ:INSMInsmed Inc
04/10/201212h01Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:INSMInsmed Inc
01/10/201220h25Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:INSMInsmed Inc
28/09/201214h23PR Newswire (US)Insmed Announces Pricing of Approximately $26 Million Direct Public OfferingNASDAQ:INSMInsmed Inc
28/09/201212h03Edgar (US Regulatory)Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP)NASDAQ:INSMInsmed Inc
12/09/201221h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INSMInsmed Inc
11/09/201215h15Dow Jones NewsInsmed Names Will Lewis as CEO; Tim Whitten Steps DownNASDAQ:INSMInsmed Inc
11/09/201214h00PR Newswire (US)Insmed Appoints Will Lewis as President and Chief Executive OfficerNASDAQ:INSMInsmed Inc
30/08/201214h00PR Newswire (US)Insmed to Present at Stifel Nicolaus 2012 Healthcare ConferenceNASDAQ:INSMInsmed Inc
14/08/201214h00PR Newswire (US)Insmed to Present at 2012 Wedbush PacGrow Life Sciences Management Access ConferenceNASDAQ:INSMInsmed Inc
07/08/201213h00PR Newswire (US)Insmed Announces Financial Results For Second Quarter And Six-months Ended June 30, 2012NASDAQ:INSMInsmed Inc
06/08/201214h00PR Newswire (US)Pharmaceutical Industry Veteran Al Altomari Elected To Insmed's Board Of DirectorsNASDAQ:INSMInsmed Inc
02/08/201214h00PR Newswire (US)Insmed Receives Second Composition Of Matter Patent For ARIKACE®NASDAQ:INSMInsmed Inc
30/07/201214h00PR Newswire (US)Insmed Announces Planned Departure Of Chief Financial OfficerNASDAQ:INSMInsmed Inc
24/07/201214h00PR Newswire (US)Insmed to Host 2012 Second Quarter Earnings Conference CallNASDAQ:INSMInsmed Inc
11/07/201212h04Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:INSMInsmed Inc
10/07/201214h00PR Newswire (US)Insmed To Present At JMP Securities 7th Annual Healthcare ConferenceNASDAQ:INSMInsmed Inc
06/07/201216h56Dow Jones NewsRegistration Effectiveness Orders Issued by the SECNASDAQ:INSMInsmed Inc
06/07/201212h02Edgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:INSMInsmed Inc
02/07/201214h00PR Newswire (US)Insmed Secures $20 Million Loan Agreement With Hercules Technology Growth CapitalNASDAQ:INSMInsmed Inc
27/06/201214h00PR Newswire (US)Insmed Announces First Patient Dosed in TARGET-NTM Phase 2 Clinical Trial of ARIKACE® in Patients with Non-Tuberculous Mycob...NASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM

Dernières Valeurs Consultées

Delayed Upgrade Clock